Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Bullboard Posts
Post by TheRock07on May 22, 2016 8:37pm
126 Views
Post# 24896817

Q10 market set for Explosive Growth

Q10 market set for Explosive Growth

Coenzyme Q10 Market Set for Explosive Growth, To Reach Around USD 850.0 Million Globally by 2020, Growing at 9.0% CAGR- Market Research Store

Global Coenzyme Q10 Market for Dietary Supplements, Pharmaceuticals, Cosmetics and Others Applications: Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Trends, Segment and Forecast 2014 – 2020

1
Source:  Market Research Store
 
 

Deerfield Beach, FL, Jan. 25, 2016 (GLOBE NEWSWIRE) -- Zion Research has published a new report titled “Coenzyme Q10 Market for Dietary Supplements, Pharmaceuticals, Cosmetics and Others Applications: Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 – 2020.” According to the report, global demand for coenzyme Q10 was valued at USD 250.0 million in 2014 and is expected to reach USD 850.0 million in 2020, growing at a CAGR of above 9.0% between 2015 and 2020. In terms of volume, the global coenzyme Q10 market stood at 745.0 kilo tons in 2014.

Coenzyme Q10 is also referred as Ubiquinone, ubidecarenone, coenzyme Q. It is a vitamin like substance which fulfills energy (ATP) requirement of different organs such as liver, heart and kidney. It is soluble in oil and present in most eukaryotic cells such as mitochondria. It is a part of electron transport chain that involves in aerobic cellular respiration and creates energy in the form of ATP. Commercially it is produced using yeast fermentation and bacterial fermentation methods. It is widely used in numerous applications as an antioxidant.

Browse the full "Coenzyme Q10 Market for Dietary Supplements, Pharmaceuticals, Cosmetics and Others Applications: Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 – 2020" report at https://www.marketresearchstore.com/report/coenzyme-q10-market-z41099

Growing cosmetics industry across the globe is a major driving factor of the coenzyme Q10 market. Cosmetic products such as sunscreen lotions and anti-ageing creams are expected to drive the global demand for CoQ10 over the forecast period. Additionally, rising usage of CoQ10 in medical applications like heart related disease, eye care, cancer treatment, obesity problem and Huntington’s disease are expected to fuel the growth of CoQ10 industry. Changing lifestyle and demand for nutritional product are also expected to trigger CoQ10 market across the world. However, controversies about uses of CoQ10 in medical application are expected to hold back the growth of CoQ10 industry to some extent.

Dietary supplement was the leading application segment for CoQ10 and accounted for over 55% share of total market volume in 2014. Growing health awareness is expected to trigger the demand for antioxidants and energy supplements. This in turn is expected to drive the demand for coenzyme Q10 over the forecast period. Pharmaceutical industry is projected to be the most lucrative application segment and expected to exhibit rapid CAGR of around 9.5% during the years to come. Demand for pharmaceutical applications is mainly driven by increasing prevalence of cardiovascular diseases.

Browse 29 Market Tables and 24 Figures spread through 70 Pages and an in-depth TOC on “Coenzyme Q10 Market - Global Size, Shares, Trends, Segment & Forecast to 2020”

Get Sample Research Report at https://www.marketresearchstore.com/report/coenzyme-q10-market-z41099#RequestSample

North America was the leading regional market for coenzyme Q10 and accounted over 50% share of the overall volume consumption in 2014. This growth owes to strong demand from U.S. North America was followed by Europe with second largest market share in global coenzyme Q10 market in 2014. Moreover, Asia Pacific is expected to grow at a rapid pace owing strong demand from China and India.


Bullboard Posts